Clinical Research Directory
Browse clinical research sites, groups, and studies.
Summary
The purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine.
Official title: Randomized, Double-blind, Controlled Trial to Investigate Combined Occipital and Supra-orbital Neuromodulation in Resistant Migraine. The RECLAIM Study.
Key Details
Gender
All
Age Range
18 Years - 84 Years
Study Type
INTERVENTIONAL
Enrollment
110
Start Date
2024-06-24
Completion Date
2029-01-31
Last Updated
2026-03-27
Healthy Volunteers
No
Interventions
PRIMUS
The Salvia PRIMUS System is designed to provide subcutaneous neurostimulation to the branches of the trigeminal and occipital nerves.
Locations (11)
Genesis Research Services
Broadmeadow, New South Wales, Australia
Resolve Pain
Buderim, Queensland, Australia
ZAS Antwerpen, Campus Sint-Augustinus
Wilrijk, Antwerpen, Belgium
Jessa Hasselt
Hasselt, Limburg, Belgium
Private Practice Dr. Sava
Saint-Nicolas, Liège, Belgium
AZ Sint Jan Brugge
Bruges, West Vlaanderen, Belgium
AZ Groeninge
Kortrijk, West Vlaanderen, Belgium
AZ Oostende
Ostend, West Vlaanderen, Belgium
AZ Delta
Roeselare, West Vlaanderen, Belgium
St. Antonius Nieuwegein
Nieuwegein, Netherlands
Erasmus MC Rotterdam
Rotterdam, Netherlands